The end effector based Gait Trainer GT II offers a safe, intensive and repetitive locomotion therapy and thus an ideal and cost efficient training for heavily affected neurological and orthopedic patients.
The GT II is based on the well known GT I which has shown positive results in extended studies and in clinical use for more than 20 years.
End effector based training has proven to be superior to conventional therapy and showed significantly better improvements in the ability to walk, walking speed and strength in the lower extremities in broad based studies over the past 20 years.
In addition, end effector based training has proven to be superior to exoskeleton based training for hemiparetic patients and is also suited to help elderly people to train their muscle strength.
The Gait Trainer has been the subject of a vast pool of scientific studies supporting the effectiveness of the device in lower extremity rehabilitation. Among others, strong evidence based and widely-accepted Cochrane reviews and 15+ scientific publications.
Would you like to get to know more details about the positive therapy effect of the Gait Trainer?